Provision of Sedation and Treatment of Seizures During Neonatal Therapeutic Hypothermia.

Neonatal Network : NN
Christopher McPherson, Keliana O'Mara

Abstract

Hypoxic-ischemic encephalopathy (HIE) produces a high rate of long-term neurodevelopmental disability in survivors. Therapeutic hypothermia dramatically improves the incidence of intact survival, but does not eliminate adverse outcomes. The ideal provision of sedation and treatment of seizures during therapeutic hypothermia represent therapeutic targets requiring optimization in practice. Physiologic stress from therapeutic hypothermia may obviate some of the benefits of this therapy. Morphine is commonly utilized to provide comfort, despite limited empiric evidence supporting safety and efficacy. Dexmedetomidine represents an interesting alternative, with preclinical data suggesting direct efficacy against shivering during induced hypothermia and neuroprotection in the setting of HIE. Pharmacokinetic properties must be considered when utilizing either agent, with safety dependent on conservative dosing and careful monitoring. HIE is the leading cause of neonatal seizures. Traditional therapies, including phenobarbital, fosphenytoin, and benzodiazepines, control seizures in the vast majority of neonates. Concerns about the acute and long-term effects of these agents have led to the exploration of alternative anticonvulsants, in...Continue Reading

References

Feb 1, 1978·The Journal of Pediatrics·M J PainterW Pitlick
Mar 1, 1992·Clinical Pharmacology and Therapeutics·P C ChayJ S Walker
Feb 8, 1990·The New England Journal of Medicine·J R FarwellK B Nelson
Nov 1, 1982·American Journal of Diseases of Children·K WatanabeM Kuroyanagi
Aug 18, 1995·Early Human Development·T R Gunn, P D Gluckman
Jan 15, 1997·The Journal of Clinical Investigation·A J GunnP D Gluckman
Aug 12, 1999·The New England Journal of Medicine·M J PainterJ Alvin
Sep 25, 2001·Pediatric Research·E C WirrellJ Y Yager
Nov 6, 2002·Proceedings of the National Academy of Sciences of the United States of America·Petra BittigauChrysanthy Ikonomidou
Jul 10, 2003·Pediatric Neurology·Mark S ScherMichael J Painter
Oct 7, 2004·European Journal of Pharmacology·Daqing MaMervyn Maze
Mar 9, 2005·Neurology·J R Castro CondeR Perera Soler
Mar 19, 2005·Pediatric Research·Danilyn M AngelesStephen Ashwal
Aug 3, 2005·Pediatrics·Vineet BhandariUNKNOWN NEOPAIN Trial Investigators Group
Feb 27, 2007·Annals of Neurology·Brandon J CornejoTimothy A Benke
Dec 20, 2007·Archives of Disease in Childhood. Fetal and Neonatal Edition·G MenonK J S Anand
Sep 17, 2008·Journal of Intensive Care Medicine·Joseph D Tobias
Feb 3, 2009·Journal of Child Neurology·Heidi K BlumeDimitri A Christakis
Oct 3, 2009·The New England Journal of Medicine·Denis V AzzopardiUNKNOWN TOBY Study Group
Jun 18, 2010·The Journal of Pediatrics·Donald F MeynWaldemar A Carlo
Jul 27, 2010·Annals of Neurology·Elavazhagan ChakkarapaniMarianne Thoresen
Sep 22, 2010·Pediatrics·Georg SimbrunerUNKNOWN neo.nEURO.network Trial Participants
Jan 24, 2012·Pediatric Neurology·Hannah C GlassDonna M Ferriero
Dec 21, 2012·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Renée A ShellhaasVarsha Bhatt-Mehta
Feb 27, 2013·The Cochrane Database of Systematic Reviews·Susan E JacobsPeter G Davis
Sep 21, 2013·Journal of Perinatology : Official Journal of the California Perinatal Association·N L MaitreA R Stark

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.